Название продукции:(+/-)-Narwedine

IUPAC Name:(1S,12S)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-one

CAS:1668-86-6
Молекулярная формула:C17H19NO3
Чистота:95%
Номер в каталоге:CM244272
Молекулярная масса:285.34

Упаковочная единица Доступно для заказа Цена ($) Количество
CM244272-250mg in stock ňň
CM244272-1g in stock ƞƄȀ
CM244272-5g in stock ňźƞ

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:1668-86-6
Молекулярная формула:C17H19NO3
Точка плавления:-
Smiles-код:O=C1C=C[C@@]23CCN(C)CC4=CC=C(OC)C(O[C@@]3([H])C1)=C24
Плотность:
Номер в каталоге:CM244272
Молекулярная масса:285.34
Точка кипения:
Номер Mdl:MFCD13193038
Хранение:

Column Infos

ZUNVEYL
Alpha Cognition announced that the FDA has granted approval for ZUNVEYL® (benzgalantamine) previously known as ALPHA-1062, for the treatment of mild-to-moderate Alzheimer’s disease. ZUNVEYL, a prodrug of AD treatment galantamine and an acetylcholinesterase inhibitor (AChEI), is postulated to exert its therapeutic effect by preventing the breakdown of acetylcholine, the important brain neurotransmitter involved in memory, motivation, and attention functions. The approval of ZUNVEYL is a pivotal moment in the fight against Alzheimer’s disease as it is only the second oral AD treatment to be approved in more than a decade.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products